Trial Profile
Micafungin and Liposomal Amphotericin B for Empirical Antifungal Therapy in Febrile Neutropenic Patients with Hematological Malignancies
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jul 2015
Price :
$35
*
At a glance
- Drugs Micafungin (Primary) ; Amphotericin B liposomal
- Indications Febrile neutropenia; Mycoses
- Focus Therapeutic Use
- 27 Jul 2015 New trial record
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.